- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
RAPT Therapeutics Inc (RAPT)
RAPT Therapeutics Inc stock price live, this page displays NASDAQ RAPT stock exchange data. View the RAPT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the RAPT Therapeutics Inc real time stock price chart below.
What Is the RAPT Therapeutics Inc Stock Price Today?
The RAPT Therapeutics Inc stock price today is 10.49.
What Is the Stock Symbol for RAPT Therapeutics Inc?
The stock symbol for RAPT Therapeutics Inc is ""RAPT.""
What Stock Exchange Does RAPT Therapeutics Inc Trade On?
RAPT Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is RAPT Therapeutics Inc a Good Stock to Buy?
Determining whether RAPT Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RAPT quote. (ISIN: US75382E2081)
What Is the RAPT Therapeutics Inc Stock Price Today?
The RAPT Therapeutics Inc stock price today is 10.49.
What Is the Stock Symbol for RAPT Therapeutics Inc?
The stock symbol for RAPT Therapeutics Inc is ""RAPT.""
What Stock Exchange Does RAPT Therapeutics Inc Trade On?
RAPT Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is RAPT Therapeutics Inc a Good Stock to Buy?
Determining whether RAPT Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RAPT quote. (ISIN: US75382E2081)
NASDAQ
Currency in USD
10.49
-0.31(-2.87%)
Closed·
After Hours
10.29-0.20(-1.91%)
·
Fair Value
An estimate of a RAPT Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.10
10.98
52 wk Range
5.67
26.56
RAPT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 3 days
More Info
Fair Value
An estimate of a RAPT Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.1010.98
52 wk Range
5.6726.56
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RAPT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a RAPT Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
24.00
Upside
+128.79%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
RAPT Therapeutics Inc Company Profile
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company’s lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
RAPT Therapeutics Inc SWOT Analysis
Pipeline Pivot | Explore RAPT's strategic shift to next-gen CCR4 antagonists following Zelnecirnon program termination, with lead candidate nomination targeted for H1 2025 |
Financial Hurdles | Delve into RAPT's cash burn rate and projected negative earnings, highlighting the potential need for capital raise and its implications for investors |
Market Potential | Learn about RAPT's positioning in the non-JAK oral treatments market for Th2-driven diseases, balancing opportunities against fierce competition |
Analyst Outlook | Discover varied analyst perspectives on RAPT, with price targets ranging from $2.00 to $4.00, reflecting the company's challenges and potential upside |
Compare RAPT to Peers and Sector
Metrics to compare | RAPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −3.5x | −0.5x | |
PEG Ratio | −0.03 | −0.01 | 0.00 | |
Price/Book | 1.0x | 2.2x | 2.6x | |
Price / LTM Sales | - | 10.2x | 3.3x | |
Upside (Analyst Target) | 105.0% | 197.5% | 45.1% | |
Fair Value Upside | Unlock | 10.6% | 7.4% | Unlock |
Analyst Ratings
3 Buy
4 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 24.00
(+128.79% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.64 / -0.1211
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does RAPT Therapeutics Trade On?
RAPT Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for RAPT Therapeutics?
The stock symbol for RAPT Therapeutics is "RAPT."
What Is the RAPT Therapeutics Market Cap?
As of today, RAPT Therapeutics market cap is 173.46M.
What Is RAPT Therapeutics's Earnings Per Share (TTM)?
The RAPT Therapeutics EPS (TTM) is -10.97.
When Is the Next RAPT Therapeutics Earnings Date?
RAPT Therapeutics will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is RAPT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has RAPT Therapeutics Stock Split?
RAPT Therapeutics has split 1 times.
How Many Employees Does RAPT Therapeutics Have?
RAPT Therapeutics has 67 employees.
What is the current trading status of RAPT Therapeutics (RAPT)?
As of 04 Aug 2025, RAPT Therapeutics (RAPT) is trading at a price of 10.49, with a previous close of 10.80. The stock has fluctuated within a day range of 10.10 to 10.98, while its 52-week range spans from 5.67 to 26.56.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.